2N7F
NMR solution structure of muO-conotoxin MfVIA
Summary for 2N7F
Entry DOI | 10.2210/pdb2n7f/pdb |
NMR Information | BMRB: 25804 |
Descriptor | muO-conotoxin MfVIA (1 entity in total) |
Functional Keywords | muo-conotoxin, diulfide-rich, toxin |
Biological source | synthetic construct |
Total number of polymer chains | 1 |
Total formula weight | 3656.41 |
Authors | Schroeder, C.I.,Mobli, M. (deposition date: 2015-09-09, release date: 2016-04-06, Last modification date: 2024-10-30) |
Primary citation | Deuis, J.R.,Dekan, Z.,Inserra, M.C.,Lee, T.H.,Aguilar, M.I.,Craik, D.J.,Lewis, R.J.,Alewood, P.F.,Mobli, M.,Schroeder, C.I.,Henriques, S.T.,Vetter, I. Development of a mu O-Conotoxin Analogue with Improved Lipid Membrane Interactions and Potency for the Analgesic Sodium Channel NaV1.8. J.Biol.Chem., 291:11829-11842, 2016 Cited by PubMed Abstract: The μO-conotoxins MrVIA, MrVIB, and MfVIA inhibit the voltage-gated sodium channel NaV1.8, a well described target for the treatment of pain; however, little is known about the residues or structural elements that define this activity. In this study, we determined the three-dimensional structure of MfVIA, examined its membrane binding properties, performed alanine-scanning mutagenesis, and identified residues important for its activity at human NaV1.8. A second round of mutations resulted in (E5K,E8K)MfVIA, a double mutant with greater positive surface charge and greater affinity for lipid membranes compared with MfVIA. This analogue had increased potency at NaV1.8 and was analgesic in the mouse formalin assay. PubMed: 27026701DOI: 10.1074/jbc.M116.721662 PDB entries with the same primary citation |
Experimental method | SOLUTION NMR |
Structure validation
Download full validation report
